Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial (Q86174679)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

main subject

systolic heart failure

1 reference

Michel Komajda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Luigi Tavazzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bernard G Francq

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Michael Böhm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jeffrey S Borer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ian Ford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Karl Swedberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

SHIFT Investigators

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

16 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Heart Failure

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1294-1301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

Review article: Diabetes mellitus and heart failure--an overview of epidemiology and management

24 February 2020

cites work

1 reference

7 January 2021

Heart failure due to systolic dysfunction and mortality in diabetes: pooled analysis of 39,505 subjects

1 reference

7 January 2021

Heart failure and diabetes mellitus: epidemiology and management of an alarming association

1 reference

7 January 2021

Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey.

1 reference

7 January 2021

Diabetes, left ventricular systolic dysfunction, and chronic heart failure

1 reference

7 January 2021

Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure

1 reference

7 January 2021

Diabetes, impaired fasting glucose, and heart failure: it's not all about the sugar.

1 reference

7 January 2021

Management of comorbid diabetes mellitus and worsening heart failure

1 reference

7 January 2021

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

1 reference

7 January 2021

Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study

1 reference

7 January 2021

Concomitant diabetes mellitus and heart failure

1 reference

7 January 2021

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

1 reference

7 January 2021

Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT).

1 reference

7 January 2021

Hypoglycaemia precipitated by propranolol

1 reference

7 January 2021

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

1 reference

7 January 2021

Resting heart rate in patients with stable coronary artery disease and diabetes: a report from the euro heart survey on diabetes and the heart

1 reference

7 January 2021

Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus

1 reference

7 January 2021

Effect of Graded Heart Rate Reduction with Ivabradine on Myocardial Oxygen Consumption and Diastolic Time in Exercising Dogs

1 reference

7 January 2021

Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients

1 reference

7 January 2021

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

1 reference

7 January 2021

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

1 reference

7 January 2021

Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.

1 reference

7 January 2021

Eplerenone in patients with systolic heart failure and mild symptoms

1 reference

7 January 2021

Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure

1 reference

7 January 2021

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

1 reference

7 January 2021

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

1 reference

7 January 2021

The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial

1 reference

7 January 2021

A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction

1 reference

7 January 2021

Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure

1 reference

7 January 2021

Predictors of mortality and morbidity in patients with chronic heart failure

1 reference

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

7 January 2021

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

1 reference

7 January 2021

Identifiers

DOI

10.1002/EJHF.347

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26377342%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference